Innovation in Bloomington
Friday, April 24: The Johnson Center for Entrepreneurship in Biotechnology will sponsor its inaugural Innovation Conference form 12:30 p.m. to 6:30 p.m. at the Indiana Memorial Union.
Speakers will cover topics related to commercializing academic research, including Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grants, IU's Spin Up program, angel investors and state and regional resources available to support new companies. Company profiles for Mapp Biopharmaceuticals and Anagin also will be presented.
San Diego-based Mapp, along with the Scripps Research Institute and other public-private partners, co-developed ZMapp, a drug that saw international media attention in 2014 for its use in treating Ebola patients Nancy Writebol and Dr. Kent Brantly. Anagin is an Indianapolis-based Spin Up company founded by IU School of Medicine professor Anantha Shekhar and Yvonne Lai, a senior scientist with IU's Department of Psychological and Brain Sciences in Bloomington. It is developing a novel treatment to battle post-traumatic stress disorder without producing the debilitating side effects that come with current treatments.
This is a great opportunity for faculty to learn how they can engage in the commercialization of their research discoveries. Interested faculty and staff should register for the conference here.